Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Maass

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Infection|September 1, 1986
Specificity and sensitivity of anti-HTLV-III/LAV determinations with a recombinant antigen competitive ELISAK O Habermehl, B Zorr, F Deinhardt, et al.
Lancet (London, England)|February 28, 1976
Letter: Blood-transfusion and hepatitisA Arndt-Hanser, H Fiedler, G Maass, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccinationG Maass, W Schmidt, M Berger, et al.
Hypertension (Dallas, Tex. : 1979)|September 15, 2010
Childhood hypertension in autosomal-dominant hypertension with brachydactylyOkan Toka, Philipp G Maass, Atakan Aydin, et al.
Andrologia|October 11, 2003
Urogenital inflammation: changes of leucocytes and ROSR Henkel, G Maass, M Hajimohammad, et al.
Human Genetics|February 1, 1992
Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis familiesT Dörk, T Neumann, U Wulbrand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parametersK Zatloukal, A Schneeberger, M Berger, et al.
Biochemistry|March 21, 1989
Genetic engineering of EcoRI mutants with altered amino acid residues in the DNA binding site: physicochemical investigations give evidence for an altered monomer/dimer equilibrium for the Gln144Lys145 and Gln144Lys145Lys200 mutantsR Geiger, T Rüter, J Alves, et al.
Human Genetics|September 1, 1990
Frequency of the F508 deletion in the CFTR gene in Turkish cystic fibrosis patientsJ Hundrieser, S Bremer, F Peinemann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1994
Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: a new approach for immunotherapy of cancerK Zatloukal, A Schneeberger, M Berger, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Infection|September 1, 1986
Specificity and sensitivity of anti-HTLV-III/LAV determinations with a recombinant antigen competitive ELISAK O Habermehl, B Zorr, F Deinhardt, et al.
Lancet (London, England)|February 28, 1976
Letter: Blood-transfusion and hepatitisA Arndt-Hanser, H Fiedler, G Maass, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccinationG Maass, W Schmidt, M Berger, et al.
Hypertension (Dallas, Tex. : 1979)|September 15, 2010
Childhood hypertension in autosomal-dominant hypertension with brachydactylyOkan Toka, Philipp G Maass, Atakan Aydin, et al.
Andrologia|October 11, 2003
Urogenital inflammation: changes of leucocytes and ROSR Henkel, G Maass, M Hajimohammad, et al.
Human Genetics|February 1, 1992
Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis familiesT Dörk, T Neumann, U Wulbrand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parametersK Zatloukal, A Schneeberger, M Berger, et al.
Biochemistry|March 21, 1989
Genetic engineering of EcoRI mutants with altered amino acid residues in the DNA binding site: physicochemical investigations give evidence for an altered monomer/dimer equilibrium for the Gln144Lys145 and Gln144Lys145Lys200 mutantsR Geiger, T Rüter, J Alves, et al.
Human Genetics|September 1, 1990
Frequency of the F508 deletion in the CFTR gene in Turkish cystic fibrosis patientsJ Hundrieser, S Bremer, F Peinemann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1994
Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: a new approach for immunotherapy of cancerK Zatloukal, A Schneeberger, M Berger, et al.
Pageof 19